Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,580 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05062239Recruiting
Statin use after valve surgery to prevent heart rhythm trouble
This study looks at whether taking statin medicines around the time of surgical aortic valve replacement can lower the chance of a common post-surgery heart rhythm problem called atrial fibrillation. It also compares statin-related factors in people who are at the time of surgery in normal rhythm and not on strong rhythm-stabilizing medicines.
OdenseAges 60–95 - NCT07338604RecruitingEarly Phase 1
UTAA07 cell therapy for relapsed CD7+ blood cancers
This trial tests a new cell therapy called UTAA07 for people with blood or lymph cancers that have returned or not responded to other treatments. It is designed for cancers that carry a specific marker called CD7, and aims to see if this therapy can help control the disease.
Suzhou, JiangsuAges 18 years+ - NCT06582693Recruiting
Tobacco treatment for families through children's hospital
This study offers proactive, personalized help to stop smoking for adults who smoke and have a child who is a patient at Children's Hospital of Philadelphia. It aims to see if this approach works better than usual care.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07253259RecruitingEarly Phase 1
Cell therapy for hard-to-treat chronic graft-versus-host disease
This study tests a new cell therapy called GT729 for people with chronic graft-versus-host disease (cGVHD) that hasn't improved with at least two previous treatments. The therapy is given as an injection and aims to help control the immune system reaction that causes cGVHD.
Tianjin, Tianjin MunicipalityAges 18–65 - NCT06664970Enrolling by invitationPhase 2
Treatment for MDS/MPN Overlap Syndrome
This study tests a combination of two drugs (azacitidine or ruxolitinib plus selinexor) for people with MDS/MPN overlap syndrome, a type of blood cancer. It aims to see if this treatment helps control symptoms and improve blood counts.
BeijingAges 18 years+ - NCT07738081Enrolling by invitation
Testing a new therapy for substance use and emotional health
This trial is testing a new type of therapy (the Unified Protocol) that helps people who are in treatment for substance use and also have depression or anxiety. The goal is to see if this approach can improve emotional well-being and reduce substance use.
OviedoAges 18 years+ - NCT06894576Recruiting
Creating a risk score for blood clot recurrence and bleeding in cancer patients
This study is for people with cancer who have had a serious blood clot. Researchers want to create a risk score that predicts who might have another clot or a bleeding problem from treatment, so they can better tailor care.
Ottawa, OntarioAges 18 years+ - NCT07325942Recruiting
Low vs high volume high-intensity interval training for heart failure
This study compares two different types of high-intensity interval exercise programs (one shorter, one longer) in people with chronic heart failure. It aims to see which program improves heart health and daily function more.
Cairo, Giza GovernorateAges 18 years+ - NCT07326813RecruitingPhase 3
Testing D-2570 for moderate to severe plaque psoriasis
This trial tests if a new oral medication called D-2570 can safely and effectively treat moderate to severe plaque psoriasis. It may be an option if your psoriasis covers a large area and has been stable for at least 6 months.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06826898Recruiting
Hydrogel to prevent scar tissue after ankle ligament repair
This trial tests a special gel placed during ankle ligament repair surgery to see if it prevents painful scar tissue from forming. It might help people with chronic ankle sprains who need surgery.
ChanghuaAges 18–60 - NCT06758882RecruitingPhase 2
Surgery with or without apalutamide for high-risk prostate cancer that has spread a little
This trial tests whether adding the drug apalutamide before and after surgery helps men with high-risk prostate cancer that has spread to a few spots (seen on a special PET scan). You would also receive standard hormone therapy.
Torino, ToAges 18–80 - NCT05815797RecruitingPhase 2
Chinese herbal formula for mild to moderate psoriasis
This trial tests an herbal formula called Shuiniujiao Dihuang Decoction for people with mild to moderate plaque psoriasis. It may help reduce psoriasis symptoms without using stronger medicines.
Hong KongAges 18–75 - NCT07658651Recruiting
Plug for type B aortic dissection repair
This trial tests a special plug (WeFlow-EndoSeal) placed into the false channel of a type B aortic dissection to help seal it. It is for people who are already getting a stent-graft and aims to improve the repair.
Beijing, Beijing MunicipalityAges 18–80 - NCT06522581RecruitingPhase 1
Citicoline for brain injury in newborns
This trial tests if citicoline, a brain-protecting supplement, can help newborns with moderate to severe brain injury from lack of oxygen. It is for babies who have not gotten cooling treatment.
RawalpindiAges 1 day–4 weeks - NCT05040815RecruitingPhase 2
Sparing inner groin nodes during early anal cancer radiation
This trial tests whether a specific radiation plan that avoids treating the inner groin lymph nodes can treat early-stage anal cancer effectively while reducing side effects. Participants may also receive chemotherapy if they are eligible.
Edmonton, AlbertaAges 18 years+ - NCT07392255RecruitingPhase 1/Phase 2
Testing CTx001 for geographic atrophy (GA) in AMD
This trial is testing a new treatment called CTx001 for people with geographic atrophy (GA), a late stage of dry age-related macular degeneration (AMD). The goal is to see if the treatment is safe and can slow vision loss.
Carmel, IndianaAges 55 years+ - NCT06752057Recruiting
Personalized vaccine plus immunotherapy and radiation for advanced lung cancer
This study tests a combination of a personalized vaccine made from your tumor's unique markers, a type of immunotherapy (PD-1 inhibitor), and radiation. The goal is to see if this mix can work better for advanced lung cancer that has progressed after initial treatment.
Nanchang, JiangxiAges 18–70 - NCT07329166Recruiting
Reducing HIV treatment interruptions in Malawi
This study tests a program to help people in Malawi stay on their HIV treatment even when they travel or move around. Researchers want to know if extra support can prevent gaps in care.
LilongweAges 15 years+ - NCT06922240RecruitingPhase 3
Stopping riociguat to see how the heart responds in CTEPH
This trial is for people with a type of long-term blood clot in the lungs (CTEPH) who have been taking riociguat for at least 12 weeks. It will see what happens when the medication is stopped, focusing on how the right side of the heart is doing.
Beijing, ChinaAges 18 years+ - NCT07242417RecruitingEarly Phase 1
TC-G203 for adults with GPC3-positive advanced solid tumors
This trial tests an experimental cell therapy (TC-G203) for people with advanced solid tumors that have a specific protein called GPC3. It aims to see if this treatment is safe and effective for those who haven't responded to standard treatments.
Beijing, Beijing MunicipalityAges 18–75 - NCT07574229Recruiting
Support System for Teens Wearing Scoliosis Braces
This study tests a new computer-based support system designed to help teenagers stay motivated and consistent with wearing their prescribed scoliosis braces. The system uses interactive tools and feedback to make brace-wearing easier and more manageable.
Shanghai, Shanghai MunicipalityAges 10–18 - NCT06460220Enrolling by invitation
Online support for parents of suicidal teens
This study tests an online course for parents of teenagers who have had suicidal thoughts, to help them better support their child. It is for families already getting care at a specific clinic at Nationwide Children's Hospital.
Columbus, OhioAges 10–18 - NCT07237373Recruiting
Heat ablation for benign thyroid nodules
This trial tests a minimally invasive procedure called thermal ablation (using heat) to shrink benign thyroid nodules that cause symptoms like pressure or cosmetic issues, or overactive (hot) nodules. It offers an alternative to surgery or radioactive iodine.
BrugesAges 18 years+ - NCT05626920RecruitingPhase 1/Phase 2
Disulfiram trial for inherited vision loss in one eye
This early-stage study tests whether disulfiram can help preserve vision in people with inherited retinal degeneration. It focuses on one study eye and uses strict eye, blood/liver, and alcohol-avoidance rules because the medicine can affect the body and needs careful safety monitoring.
Seattle, WashingtonAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,580 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.